Inventor · disambiguated record
Michael K. Ameriks
Also filed as: AMERIKS MICHAEL · AMERIKS MICHAEL K
26 granted patents·15 pending applications·18 citations·filing 2004–2025
93Inventor score
Top patents by PatentIndex Score
41 records- 0190US11820766B2Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 21, 2023·2 cites·93 claims
- 0290US11708359B2Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 25, 2023·2 cites·28 claims
- 0387US11897872B2Azaspirocycles as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 13, 2024·1 cites·15 claims
- 0485US11802111B2Cyclobutyl amide monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 31, 2023·1 cites·23 claims
- 0585US9040534B2[1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 26, 2015·6 cites·20 claims
- 0683US2024327410A1Monoacylglycerol Lipase ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0782US12145934B2Azabenzimidazoles and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 19, 2024·0 cites·4 claims
- 0882US12139485B2Azabenzimidazoles and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 12, 2024·0 cites·4 claims
- 0982US11787798B2Aryl piperidines as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 17, 2023·1 cites·18 claims
- 1082US11505546B2Azaspirocycles as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 22, 2022·1 cites·18 claims
- 1179US11993601B2Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted May 28, 2024·0 cites·20 claims
- 1276US2024208914A1Aminocyclobutanes as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1375US11919870B2Aminocyclobutanes as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Mar 5, 2024·0 cites·15 claims
- 1475US11312712B2Azabenzimidazoles and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Apr 26, 2022·1 cites·11 claims
- 1575US2024239776A1Azaspirocycles as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1674US10100045B23-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 16, 2018·1 cites·16 claims
- 1773US2020102311A1Monoacylglycerol Lipase ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1871US10155769B2Fused azaheterocyclic compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 18, 2018·1 cites·26 claims
- 1971US10087185B2Fused bicylic pyridine compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 2, 2018·1 cites·26 claims
- 2071US2024208902A1Cyclobutyl amide monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2170US11597728B2Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Mar 7, 2023·0 cites·83 claims
- 2270US11512059B2Aminocyclobutanes as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 29, 2022·0 cites·16 claims
- 2370US2024228484A1Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2470US2023382902A1Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2569US2024092781A1Aryl piperidines as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2667US12304908B2Azabenzimidazoles and their use as AMPA receptor modulatorsRAPPORT THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·2 claims
- 2767US2025230157A1Azabenzimidazoles and their use as ampa receptor modulatorsRAPPORT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2867US2020102303A1Monoacylglycerol Lipase ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2961US11891387B2Monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Feb 6, 2024·0 cites·19 claims
- 3061US10053463B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 21, 2018·0 cites·33 claims
- 3161US2025282768A1Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3258US7687639B2Substituted benzimidazoles and imidazo-[4,5]-pyridinesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 30, 2010·0 cites·23 claims
- 3351US10047092B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Aug 14, 2018·0 cites·11 claims
- 3451US7132440B2Substituted benzimidazoles and imidazo-[4,5]-pyridinesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Nov 7, 2006·0 cites·17 claims
- 3547US10611730B2Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Apr 7, 2020·0 cites·19 claims
- 3647US2008200454A1Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin sAMERIKS MICHAEL K·Filed 2008·Application pending·0 cites
- 3746US2009118274A1Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin sALLEN DARIN·Filed 2008·Application pending·0 cites
- 3846US2008269241A1Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin sALLEN DARIN·Filed 2008·Application pending·0 cites
- 3946US2009099157A1Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin sAMERIKS MICHAEL K·Filed 2008·Application pending·0 cites
- 4039US10513523B2Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 24, 2019·0 cites·38 claims
- 4136US10604484B2Indolone compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Mar 31, 2020·0 cites·39 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →